Format

Send to

Choose Destination
Blood Cancer J. 2019 Jan 15;9(2):5. doi: 10.1038/s41408-018-0169-1.

The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia.

Author information

1
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
2
Lund Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden.
3
Division of Oncology, Skåne University Hospital, Lund, Sweden.
4
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden. kazi.uddin@med.lu.se.
5
Lund Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden. kazi.uddin@med.lu.se.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center